Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02922881 · ClinicalTrials.gov registry record · NA

Microbiota-targeted Diet for Pediatric UC

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT02922881 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02922881, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

Ulcerative colitis is a chronic inflammatory disease primarily involving the colon and has long been considered to be due to a dysregulated immune response targeting the colon, and involves unknown environmental factors. Currently, no effective therapy targets the microbiota or its interaction with the colonic epithelium. Diet has a significant impact on the composition of the microbiota; however, no dietary intervention to date has proven effective for induction of remission. The primary objective of this study is to determine whether the Ulcerative Colitis Diet (UCD) can induce remission or response in pediatric UC patients with active mild to moderate UC on a stable medication.

Interventions

  • OTHER Ulcerative Colitis Diet (UCD)

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2017-03-08
Est. Completion 2021-09-30
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT02922881

The ClinicalTrials.gov registry entry for NCT02922881 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Ulcerative Colitis Diet (UCD) is the first listed.

NCT02922881 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02922881 about?

NCT02922881 is a clinical study titled "Microbiota-targeted Diet for Pediatric UC". Ulcerative colitis is a chronic inflammatory disease primarily involving the colon and has long been considered to be due to a dysregulated immune response targeting the colon, and involves unknown environmental factors. Currently, no effective therapy targets the microbiota or its interaction with ...

What is the current status of trial NCT02922881?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2017-03-08. Estimated completion is 2021-09-30.

What interventions are being tested in trial NCT02922881?

The interventions under investigation include: Ulcerative Colitis Diet (UCD) (OTHER).

Who is sponsoring clinical trial NCT02922881?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.